510(k) Report

FDA applicant

Pear Therapeutics, Inc.

Boston, MA3 decisions2017–20202 recalls

FDA records 3 decisions for Pear Therapeutics, Inc. (Boston, MA) from 2017 to 2020: 2 510(k) clearances and 1 De Novo grant. Most are in product codes PWE (Computerized Behavioral Therapy Device For…) and QVO (Computerized Behavioral Therapy Device For…). Its devices cite 1 predicate, 1 of them its own earlier devices. 2 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, neurology panel, where it files most

How often FDA has decided Pear Therapeutics, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2020

2017: 12018: 12020: 1
2017high 1 (2017) · low 0 (2019)2026

2026 so far, outlined.

Recalls per year

2in 2021

2021: 2
2017high 2 (2021) · low 0 (2017)2026

Class I Class II/III not classified

FIG. 1 — Pear Therapeutics, Inc. by year, 2017–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Pear Therapeutics, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report